NO162241C - Nye, radioaktive estradienderivater merket med jod125, fremgangsmaate ved deres fremstilling og deres anvendelse vedradioimmunologisk undersoekelse og mengdebestemmelse av steroider i biologiske vaesker. - Google Patents

Nye, radioaktive estradienderivater merket med jod125, fremgangsmaate ved deres fremstilling og deres anvendelse vedradioimmunologisk undersoekelse og mengdebestemmelse av steroider i biologiske vaesker.

Info

Publication number
NO162241C
NO162241C NO842287A NO842287A NO162241C NO 162241 C NO162241 C NO 162241C NO 842287 A NO842287 A NO 842287A NO 842287 A NO842287 A NO 842287A NO 162241 C NO162241 C NO 162241C
Authority
NO
Norway
Prior art keywords
jod125
dimmunological
estradia
steroids
research
Prior art date
Application number
NO842287A
Other languages
English (en)
Other versions
NO842287L (no
NO162241B (no
Inventor
Alain Jouquey
Jean Salmon
Michel Mouren
Gaetan Touyer
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR8309812A external-priority patent/FR2549067B1/fr
Priority claimed from FR8310142A external-priority patent/FR2548192B1/fr
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of NO842287L publication Critical patent/NO842287L/no
Publication of NO162241B publication Critical patent/NO162241B/no
Publication of NO162241C publication Critical patent/NO162241C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • C07J41/0016—Oximes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
    • C07J41/0083—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/534—Production of labelled immunochemicals with radioactive label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/743—Steroid hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Endocrinology (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO842287A 1983-06-14 1984-06-07 Nye, radioaktive estradienderivater merket med jod125, fremgangsmaate ved deres fremstilling og deres anvendelse vedradioimmunologisk undersoekelse og mengdebestemmelse av steroider i biologiske vaesker. NO162241C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8309812A FR2549067B1 (fr) 1983-06-14 1983-06-14 Derives estradieniques radioactifs marques au tritium, leur procede de preparation et leur application pour l'etude et le dosage radio-immunologique de steroides dans les fluides biologiques
FR8310142A FR2548192B1 (fr) 1983-06-20 1983-06-20 Derives estradieniques radioactifs marques a l'iode, leur procede de preparation et leur application aux dosages radioimmunologiques

Publications (3)

Publication Number Publication Date
NO842287L NO842287L (no) 1984-12-17
NO162241B NO162241B (no) 1989-08-21
NO162241C true NO162241C (no) 1989-11-29

Family

ID=26223479

Family Applications (1)

Application Number Title Priority Date Filing Date
NO842287A NO162241C (no) 1983-06-14 1984-06-07 Nye, radioaktive estradienderivater merket med jod125, fremgangsmaate ved deres fremstilling og deres anvendelse vedradioimmunologisk undersoekelse og mengdebestemmelse av steroider i biologiske vaesker.

Country Status (5)

Country Link
US (1) US4639336A (no)
EP (1) EP0131491A1 (no)
CA (1) CA1226573A (no)
FI (1) FI842399A (no)
NO (1) NO162241C (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0178683B1 (en) * 1984-10-19 1989-08-09 Nihon Medi-Physics Co., Ltd. Imunoassay for estriol-3-sulfate
JPS62162963A (ja) * 1986-01-10 1987-07-18 Sadao Shiosaka 金属コロイド粒子を担体とする低分子物質に対する特異抗体の作成法
FR2627588A1 (fr) * 1988-02-24 1989-08-25 Ire Medgenix Sa Procede de dosage immunologique d'une substance de structure haptenique
US6274552B1 (en) 1993-03-18 2001-08-14 Cytimmune Sciences, Inc. Composition and method for delivery of biologically-active factors
US20010055581A1 (en) * 1994-03-18 2001-12-27 Lawrence Tamarkin Composition and method for delivery of biologically-active factors
US6407218B1 (en) 1997-11-10 2002-06-18 Cytimmune Sciences, Inc. Method and compositions for enhancing immune response and for the production of in vitro mabs
US7229841B2 (en) * 2001-04-30 2007-06-12 Cytimmune Sciences, Inc. Colloidal metal compositions and methods
CA2548179A1 (en) * 2003-12-02 2005-07-21 Cytimmune Sciences, Inc. Methods and compositions for the production of monoclonal antibodies
EP1715971A4 (en) * 2004-01-28 2010-10-13 Cytimmune Sciences Inc FUNCTIONALIZED COLLOIDAL METAL COMPOSITIONS AND METHODS
CN102203002A (zh) * 2007-09-21 2011-09-28 细胞免疫科学公司 纳米治疗性胶态金属组合物和方法
US20110014118A1 (en) * 2007-09-21 2011-01-20 Lawrence Tamarkin Nanotherapeutic colloidal metal compositions and methods
WO2009062151A1 (en) 2007-11-08 2009-05-14 Cytimmune Sciences, Inc. Compositions and methods for generating antibodies

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2467477A (en) * 1976-05-10 1978-11-02 Beckman Instruments Inc 1125 imidazole steroid derivatives
US4358435A (en) * 1980-06-09 1982-11-09 The Research Foundation Of State University Of New York Ligand compositions and processes for their manufacture and their use in radioimmunoassay
ZA8231B (en) * 1981-01-09 1982-11-24 Roussel Uclaf New 11 -substituted steroid derivatives, their preparation, their use as medicaments, the compositions containing them and the new intermediates thus obtained

Also Published As

Publication number Publication date
FI842399A0 (fi) 1984-06-13
NO842287L (no) 1984-12-17
NO162241B (no) 1989-08-21
US4639336A (en) 1987-01-27
CA1226573A (fr) 1987-09-08
FI842399A (fi) 1984-12-15
EP0131491A1 (fr) 1985-01-16

Similar Documents

Publication Publication Date Title
NO870572L (no) Fremgangsmaate og innretning for finfordeling av malm med lavt energiforbruk.
NO871729D0 (no) Framgangsmaate for aa frambringe paasproeytede belegg, apparat for gjennomfoering av framgangsmaaten og gjenstander tilvirket i samsvar med framgangsmaaten.
NO166588C (no) Nye katalysepreparater, samt deres anvendelse ved fremstilling av polymerer.
DK286786D0 (da) Hydrogeldannende polymersammensaetning, fremgangsmaade til fremstilling af samme samt absorberende struktur og artikel indeholdendesammensaetningen
IT8124835A0 (it) Nuovi derivati di nor-tropano e granatano, loro procedimento di preparazione e loro applicazione in terapia.
NO159939C (no) Varmelagringsmateriale med reversibel flytende/fast-faseforandring og anvendelse derav.
NO162241C (no) Nye, radioaktive estradienderivater merket med jod125, fremgangsmaate ved deres fremstilling og deres anvendelse vedradioimmunologisk undersoekelse og mengdebestemmelse av steroider i biologiske vaesker.
NO904333D0 (no) 9alfa-hydroksy-17-metylensteroider, fremgangsmaate ved fremstilling derav og anvendelse derav ved fremstilling av corticosteroider.
DE3574774D1 (de) Vorrichtung zur dimensionsmessung, insbesondere diametral- und axialdimensionen von teilen mit rotationssymmetrie.
DE3481624D1 (de) Fluessige reaktivfarbstoffzubereitungen und ihre verwendung.
DK507685A (da) Tricycliske pyridinderivater, deres fremstilling og anvendelse samt ved fremstillingen anvendelige udgangsmaterialer
NO165683C (no) Kvaternaere oksalkylerte polykondensater, fremgangsmaate til deres fremstilling, og deres anvendelse.
DK158522C (da) Beta-amylase, samt fremstilling og anvendelse deraf
DK621486D0 (da) 1-benzensulfonyl-2-oxo-5-alkoxypyrrolidinderivater samt deres fremstilling, anvendelse og praeparater med indhold deraf
NO820213L (no) Kjemiske forbindelser, deres fremstilling og deres anvendelse i legemidler
DK445187D0 (da) Apparat til undersoegelse af fejl i materialer, isaer i stoebegods
NO851452L (no) Fremgangsmaate og cellelinje for fremstilling av plasminogene aktivatorer.
NO153098C (no) 3-substituerte 2,2-dimethyl-cyclopropancarboxylsyrer og lavere alkylestere derav som er anvendelige som utgangsmaterialer ved fremstilling av pyrethroider med insekticid virkning
IT8921789A0 (it) Reattivo per la ricerca e la determinazione della bilirubina nelle urine.
NO166726C (no) Fremgangsmaate for fremstilling av arylglycidyletere og 3-substituerte 1-alkylamino-2-propanoler.
IT1153062B (it) Derivati benzilidenici, loro preparazione e loro applicazione in terapia
DE3587644D1 (de) Flüssigkristalltemperaturfühler und materialien dazu.
DE3682105D1 (de) Probe, tracers, immunogene und antikoerper von ethosuximid.
DK545687D0 (da) Anti-idiotype antistoffer, fremgangsmaade til deres fremstilling samt analysefremgangsmaader med udnyttelse af disse antistoffer
IT1190782B (it) Derivati diossazabiciclici,loro procedimento di preparazione e loro applicazione in terapia